Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma
Xugang Zhong(Zhejiang Provincial People's Hospital), Senbo Zhu(Zhejiang Provincial People's Hospital), Qing Bi(Zhejiang Provincial People's Hospital), Tong Yu(Wenzhou City People's Hospital), Zheping Hong(Zhejiang Provincial People's Hospital), Zeju He(Wenzhou Medical University), Yin Li(Wenzhou Medical University), Yong Fan(Wenzhou Medical University)
Cited by 14
Related Papers
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study
|Journal of Clinical Oncology|2022|306
Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning
|Scientific Reports|2023|45
Association of visceral and subcutaneous fat with bone mineral density in US adults: a cross-sectional study
|Scientific Reports|2023|24
Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study
|Frontiers in Public Health|2022|22
Bone metastasis risk and prognosis assessment models for kidney cancer based on machine learning
|Frontiers in Public Health|2022|22